On December 9, Gelonghui reported that jinhai med tech (02225.HK) announced that the Securities Regulatory Commission had recently inquired about the company's shareholding distribution. The inquiry results showed that as of November 20, 2024, there were a total of 27 shareholders and their related parties holding 0.53328 billion shares of the company, accounting for 41.26% of the company's issued share capital. In addition to this equity, the company chairman and executive director holds 0.6325 billion shares (representing 48.94% of the issued share capital), which accounts for 90.20% of the company's issued share capital. Therefore, only 0.12672 billion shares (representing 9.80% of the issued share capital) are held by other shareholders.